Deborah Heart and Lung Center Implants Novel Heart Failure Therapy

Barostim™ uses the power of the brain and nervous system to improve symptoms for patients with systolic heart failure

From left, Dr. Gregory Domer (second from left), with the surgical team at Deborah Heart and Lung Center after a procedure to implant the Barostim™ device.

Browns Mills, New Jersey - Deborah Heart and Lung Center successfully implanted the Barostim™ device, an innovative heart failure therapy that uses the power of your brain to treat heart failure symptoms. More than 6.9 million adults in the United States live with heart failure, according to the Centers for Disease Control and Prevention and that number is estimated to increase by 24% to nearly 8.5 million adults by the year 2030. Heart failure can develop suddenly or over time as the heart gets weaker and can affect one or both sides of the heart. As a chronic, progressive condition requiring lifelong management, patients with heart failure seek effective treatments - medications, procedures, and devices - to relieve their heart failure symptoms and improve their quality of life.

Despite advancements in heart failure medications and technologies, some patients continue to experience symptoms that impact their daily life. Barostim™ is a novel device option designed to help patients with heart failure who may not be receiving adequate symptom relief from their medications alone and are not eligible for a pacemaker.

Barostim™ works by stimulating baroreceptors - natural pressure sensors located in the wall of the carotid artery - that tell the nervous system how to regulate heart, kidney and vascular functions. These effects reduce the heart's workload and help it pump more efficiently, helping to restore balance of the autonomic nervous system and improve the symptoms of heart failure.

"We are thrilled to offer this new heart failure technology to our patients," said Gregory Domer, MD, division director, Vascular Surgery, Deborah Heart and Lung Center. "Studies show that Barostim™ patients had three times greater improvement in quality of life scores than patients on medications alone. We look forward to the integration of the Barostim™ into our treatment plan to help relieve the symptoms of heart failure. "

About Deborah Heart and Lung Center

Deborah Heart and Lung Center in Browns Mills, New Jersey is a teaching hospital in the prevention, diagnosis, research and treatment of heart, lung and vascular diseases. Founded in 1922, Deborah has treated more than 2.3 million hearts from every corner of the United States and 87 countries. From performing the first adult and pediatric open-heart surgeries in New Jersey, to one of the highest-volume left-ventricular assist device (LVAD) implant programs in the nation, Deborah is consistently recognized as a leader overall and in patient care from the Centers for Medicare and Medicaid Services (CMS).

It is ranked among the top hospitals in New Jersey for patient satisfaction; holds a top-tier Society of Thoracic Surgeons rating, which places Deborah among the best cardiac surgery programs in North America; and is rated High Performing in five specialties, Heart Attack, Heart Bypass Surgery, Heart Failure, COPD and TAVR by U.S. News & World Report. Deborah is an Alliance member of the Cleveland Clinic Heart, Vascular & Thoracic Institute. To learn more about Deborah, visit https://demanddeborah.org/.

Public link

Please use the above public link if you want to share this noodl on another website.